Skip to main navigation

Home
Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Press Releases

Press Releases

Year

December 14, 2020

Athira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors

December 8, 2020

Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease

December 1, 2020

Athira Pharma Announces Initiation of Patient Dosing for ACT-AD Clinical Trial of ATH-1017, Small Molecule HGF/MET Activator, for Treatment of Mild-to-Moderate Alzheimer’s Disease

November 12, 2020

Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights

November 10, 2020

Athira Pharma to Present at Upcoming November Investor Conferences

October 21, 2020

Athira Pharma to Host Educational Webinar on the Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease Treatments

October 1, 2020

Athira Pharma Announces Initiation of Patient Dosing for the LIFT-AD Study, a Phase 2/3 Clinical Trial to Evaluate ATH-1017 for Treatment of Mild-to-Moderate Alzheimer's Disease

September 22, 2020

Athira Pharma Announces Closing of Initial Public Offering

September 17, 2020

Athira Pharma Announces Pricing of Initial Public Offering

June 4, 2020

Athira Pharma Closes $85 Million Series B Financing

Pagination

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Next page
Last page

Displaying 121 - 130 of 139

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

info@athira.com

© Athira Pharma, Inc. All rights reserved.